Irvine (August 29-30, 2006)
Personnel attending this interactive program will have an opportunity to learn how to prepare for an FDA inspection, what to expect during interaction with FDA officials and how to respond to FDA observations. Additionally this course is a good refresher for all personnel involved in the FDA inspection process and an opportunity to compare your internal audit system against what a leading internal audit expert believes is the best approach to implement. The course is provided in an informal atmosphere and an easily understood format.
The following are examples of some of the issues addressed during the course:
What your organization can do to prepare for the inspection What information can the FDA request during an inspection Can a Warning Letter be issued immediately after an FDA inspection When can the FDA take action without issuing to a Warning Letter What does the FDA look for during inspections How does the FDA classify a recall What are the timeframes for the U.S. DOJ's and FDA's handling of clear criminal fraud cases What type of documentation is required and what is the correct format What do the FDA's export regulations mean to your firm What types of cases does the FDA refer to the DOJ for prosecution When can the FDA suspend, deny or withdraw abbreviated new drug applications (ANDAs) How to respond to FDA actions Under what conditions can the FDA debar companies and individuals What to do after the FDA has taken action
More: http://www.cfpie.com/showitem.aspx?productid=033&source=poe
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology links - Useful biotech links for you
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Mashed up purple marine bacteria makes an excellent eco-friendly fertilizer
Spinning artificial spider silk into next-generation medical materials